These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6177604)

  • 21. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
    Tan SH; Doraisamy G; Noriah R; Lopez CG
    Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of haemostatic mechanisms.
    Ratnoff OD
    Clin Haematol; 1981 Jun; 10(2):261-81. PubMed ID: 7032777
    [No Abstract]   [Full Text] [Related]  

  • 24. Application of several chromogenic substrate assays to automated instrumentation for coagulation analysis.
    Bartl K; Becker U; Lill H
    Semin Thromb Hemost; 1983 Oct; 9(4):301-8. PubMed ID: 6658461
    [No Abstract]   [Full Text] [Related]  

  • 25. Index of suspicion. Case 3. Antithrombin III deficiency.
    Nussbaum D
    Pediatr Rev; 1997 Aug; 18(8):283, 285-6. PubMed ID: 9255997
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of colorimetric, fluorometric and spectrophotometric methods for measuring antithrombin III using synthetic substrates].
    Uete T
    Rinsho Byori; 1984 Nov; 32(11):1258-62. PubMed ID: 6520982
    [No Abstract]   [Full Text] [Related]  

  • 27. Selected hemostatic abnormalities associated with neoplastic disease.
    Ito R; Statland BE
    Clin Lab Med; 1982 Sep; 2(3):599-625. PubMed ID: 6814812
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coagulation parameters in patients with hypertension].
    García E; Rodríguez M; Díez ML; Navarro A
    Rev Esp Fisiol; 1982; 38 Suppl():277-80. PubMed ID: 7146584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False assignment of familial antithrombin III deficiency with the von Kaulla assay.
    Cosgriff TM; Hershgold EJ; Martin BA; Carlson KS
    Am J Clin Pathol; 1983 Nov; 80(5):697-9. PubMed ID: 6416053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of blood coagulation disorders].
    Vorob'ev PA
    Feldsher Akush; 1987 Feb; 52(2):50-5. PubMed ID: 3646971
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antithrombin III and its role in normal and pathological hemostasis].
    Bŭchvarova V; Doĭchinov A; Angelova N
    Vutr Boles; 1981; 20(6):34-8. PubMed ID: 7039127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of antithrombin III in disorders of blood coagulation].
    Król-Grela H; Piastucka B; Skotnicki AB
    Przegl Lek; 1988; 45(6):516-20. PubMed ID: 3075308
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antithrombin III: critical review of the methods used for its monitoring in thrombophilic states].
    Modiano A; Belisario A
    G Clin Med; 1981 Sep; 62(9):597-608. PubMed ID: 7033027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Genetic diagnosis of hereditary coagulation disorders].
    Ozawa T
    Rinsho Byori; 1998 Jan; 46(1):43-8. PubMed ID: 9492537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
    Koresawa S; Matsuda N; Ueda S
    Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
    [No Abstract]   [Full Text] [Related]  

  • 37. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antithrombin III in clinical practice].
    Monreal M; Rodríguez R; Monasterio I
    Med Clin (Barc); 1982 Jun 16-30; 79(2):91-3. PubMed ID: 7121115
    [No Abstract]   [Full Text] [Related]  

  • 39. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
    van Voorthuizen H; Kluft C
    Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.